Prostate treatment lasts, preserves fertility

March 24, 2014, Society of Interventional Radiology

Shrinking the prostate without surgery can provide long-term relief to men with this common condition that causes annoying symptoms, such as frequent trips to the bathroom, suggests a study of nearly 500 men. According to research being presented at the Society of Interventional Radiology's 39th Annual Scientific Meeting, 72 percent of men experienced symptom improvement three years after having a new, minimally invasive, image-guided treatment performed by interventional radiologists called prostate artery embolization (PAE).

"The results of artery embolization (PAE) are similar to surgery but with fewer complications," said Martins Pisco, M.D., Ph.D., lead author of the study and director of radiology at Saint Louis Hospital, Lisbon, Portugal. "Patients are discharged three to six hours after the treatment with most of the individuals we've treated noting almost immediate symptom relief," he said, adding, "I believe PAE could eventually become standard treatment for ."

As a man ages, the slowly grows bigger (or enlarges) and may press on the urethra and cause the flow of urine to be slower and less forceful. Enlarged prostates cause urinary frequency, urgency, passing urine more often (particularly at night), weakened stream and incomplete bladder emptying.

"Such symptoms can have significant negative impact in quality of life, leading many men to seek treatment," said Pisco, noting that this condition affects more than half of men by age 60. The standard treatment for or BPH, which is the medical name for enlarged prostate, is surgery, which requires general anesthesia and can cause complications, such as urinary incontinence, sexual dysfunction, impotence and retrograde ejaculation, in which semen enters into the bladder. PAE, which can be performed under local anesthesia, involves temporarily blocking to the arteries that supply the prostate, a treatment called embolization, explained Pisco.

"Our study confirmed that PAE does not cause and preserves fertility," said Pisco, who indicated that this is the largest study of its kind. In fact, 148 (31.6 percent) of our treated patients reported improved sexual function, he noted. "We also found that the larger the prostate and the more severe the symptoms are, the better the results of PAE," said Pisco.

Success rates in 469 patients (ages 45−89) treated with PAE were as follows: 87.2 percent at three months, 80.2 percent at 18 months and 72.3 percent at three years. One patient suffered from lack of blood flow to the bladder wall that was corrected by surgery, and one patient had pain that lasted three months. In cases where the problem recurred, it often could be re-treated with PAE, Pisco said.

With PAE, an interventional radiologist makes a tiny incision in the groin and advances a small tube, called a catheter, to the prostate artery. Microscopic beads are released into the artery, where they lodge and temporarily block blood flow to the prostate, causing it to shrink. PAE currently is the focus of several U.S. trials.

"These results are very promising for American men," said SIR President-elect James B. Spies, M.D., MPH, FSIR. Spies, who is a principal investigator on one the ongoing U.S. PAE trials, noted that this treatment is an advanced embolization procedure requiring rigorous training and a detailed knowledge of the prostate anatomy and surrounding vessels. "Interventional radiologists are leaders in bringing forth new treatments such as these responsibly," said Spies, chair of the radiology department at Medstar Georgetown University Hospital and professor of radiology at Georgetown University Medical Center in Washington, D.C. He noted that additional study is needed to further establish the safety, efficacy and durability of this treatment before it will become broadly available in clinical practice.

Explore further: Nonsurgical treatment turns back the clock, shrinks enlarged prostate

More information: Abstract 108: "Prostate Arterial Embolization as an Alternative to Surgery for Patients With Benign Prostatic Hyperplasia Refractory to Medical Therapy: Results in 500 Cases," J.M. Pisco, M.D; T. Bilhim, M.D.; L. Campos Pinheiro, M.D.; H. Rio Tinto, M.D.; L.C. Fernandes, M.D.; J. Pereira, M.D.; M. Duarte, M.D.; A. Oliveira, M.D., Ph.D.; Saint Louis Hospital, Lisbon, Portugal, SIR Annual Scientific Meeting, March 22-27. This abstract can be found at www.SIRmeeting.org

Related Stories

Nonsurgical treatment turns back the clock, shrinks enlarged prostate

April 15, 2013
Men with a common condition that causes frequent nighttime trips to the bathroom can get relief with a minimally invasive treatment that shrinks the prostate, suggests a study being presented at the Society of Interventional ...

Blood vessel treatment might reduce symptoms of enlarged prostate

January 22, 2014
(HealthDay)—A new nonsurgical treatment for enlarged prostate might help ease symptoms such as frequent urination at night, Brazilian researchers report.

Interventional radiology: Potential breakthrough to treat men's enlarged prostate

March 25, 2012
A new interventional radiology treatment, prostatic artery embolization, may bring hope to men with debilitating symptoms caused by an enlarged prostate, say the group of researchers who pioneered its use. The findings were ...

FDA OKs implant for enlarged prostate symptoms

September 13, 2013
(AP)—Federal health regulators have approved the first permanent implant to treat men's urinary problems caused by an enlarged prostate.

With flip of wrist, interventional radiologists treat uterine fibroids

March 5, 2014
Interventional radiologists have devised a new way to access a woman's fibroids—by flipping her wrist and treating via an arm not groin artery—to nonsurgically shrink noncancerous growths in the muscular wall of the uterus. ...

Recommended for you

Creation of synthetic horsepox virus could lead to more effective smallpox vaccine

January 19, 2018
UAlberta researchers created a new synthetic virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to ...

Study ends debate over role of steroids in treating septic shock

January 19, 2018
The results from the largest ever study of septic shock could improve treatment for critically ill patients and save health systems worldwide hundreds of millions of dollars each year.

New approach could help curtail hospitalizations due to influenza infection

January 18, 2018
More than 700,000 Americans were hospitalized due to illnesses associated with the seasonal flu during the 2014-15 flu season, according to federal estimates. A radical new approach to vaccine development at UCLA may help ...

Zika virus damages placenta, which may explain malformed babies

January 18, 2018
Though the Zika virus is widely known for a recent outbreak that caused children to be born with microencephaly, or having a small head, and other malformations, scientists have struggled to explain how the virus affects ...

Certain flu virus mutations may compensate for fitness costs of other mutations

January 18, 2018
Seasonal flu viruses continually undergo mutations that help them evade the human immune system, but some of these mutations can reduce a virus's potency. According to new research published in PLOS Pathogens, certain mutations ...

Study reveals how MRSA infection compromises lymphatic function

January 17, 2018
Infections of the skin or other soft tissues with the hard-to-treat MRSA (methicillin-resistant Staphylococcus aureus) bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.